Blog

Sep 3, 2019

A Molecule Designed By AI Exhibits ‘Druglike’ Qualities

Posted by in categories: biotech/medical, robotics/AI

Why the rush? It now costs $2.6 billion, by one estimate, to get a new drug to market, and pipelines are only getting slower and more expensive. There’s hope—and hype—that AI could help chip away at that figure by reducing the time and labor before a drug starts clinical trials. The idea is that the same techniques used to generate realistic deepfakes and deftly play Go might be able to decipher the complex rules of drug design and generate molecules from scratch.


Insilico Medicine is among several startups trying to harness artificial intelligence to speed to development of drugs.

Leave a reply